Improving lung imaging techniques for better health assessments
Official title: A prospective study to support validation of lung deposition models with nuclear medicine imaging methods
Funded at Fluidda, INC. · NIH-10928212 · Data updated 2026-11-12
This study is working on new imaging techniques to better understand how medicines and other substances settle in the lungs, which could help improve treatments for people with lung conditions.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fluidda, INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 5, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $332,174 |
| NIH project number | 5U01FD007987-02 |
| Project ID | NIH-10928212 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would be individuals with respiratory conditions who require detailed lung imaging for diagnosis or treatment planning.
✕Less likely to help
Patients without respiratory issues or those who do not require lung imaging may not benefit from this research.
What this research studies
This research focuses on developing advanced nuclear imaging protocols using techniques like SPECT and PET to improve the accuracy of lung deposition models. By collaborating with the FDA, the project aims to collect high-resolution imaging data that can enhance our understanding of how medications and other substances are deposited in the lungs. The study will utilize cutting-edge technology to achieve better spatial and temporal resolution, allowing for more precise localization of radiotracer activity within the lung's intricate structures. This could lead to improved models that better reflect individual variations in lung anatomy and disease.
Why it matters
Potential benefit: If successful, this research could lead to more accurate assessments of lung function and improved treatment strategies for respiratory conditions.
How similar studies have gone: While the approach of using advanced imaging techniques is established, the specific application to validate lung deposition models represents a novel advancement in the field.
Where this research is happening
-
Fluidda, INC.
New York, United States Active
Researchers
- Principal investigator: Lavon, Benjamin — Fluidda, INC.
- Study coordinator: Lavon, Benjamin
Related research
Other NIH-funded projects on the same topics.
-
Better lung imaging to map where inhaled medicines and particles go
This project will use advanced PET or SPECT scans combined with CT maps to show where inhaled particles deposit in people's lungs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.